Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Editorial: New strategies to o...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Editorial: New strategies to overcome platinum resistance in ovarian cancer

Editorial: New strategies to overcome platinum resistance in ovarian cancer

Bibliographic Details
Main Authors: Jian-Jun Wei, Fabio Martinelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Oncology
Subjects:
ovarian cancer
cancer therapy
carboplatin resistance
editorial
drug development
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1390760/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1390760/full

Similar Items

  • Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
    by: Jian Chen, et al.
    Published: (2009-09-01)
  • A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    by: Shoji Nagao, et al.
    Published: (2020-02-01)
  • Modern strategies of platinum resistance overcoming in patients with the serous ovarian cancer
    by: Andriy Rybin
    Published: (2018-11-01)
  • Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells
    by: Venkata Ramesh Dasari, et al.
    Published: (2020-04-01)
  • Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer
    by: Blagden Sarah, et al.
    Published: (2011-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs